Relapse-Free Survival as a Surrogate for Overall Survival in the Evaluation of Stage II–III Melanoma Adjuvant Therapy
JNCI: Journal of the National Cancer Institute | June 12, 2017 | Volume: 110 | Issue: 1 | Pages: 87-96
10.1093/jnci/djx133
| PMID 28922786